Orientations
Interim recommendations for use of the CanSinoBIO Ad5-nCoV-S [recombinant] vaccine (Convidecia™) against COVID-19
Interim recommendations for use of the CanSinoBIO Ad5-nCoV-S [recombinant] vaccine (Convidecia™) against COVID-19: interim guidance, first issued 19 May 2022
Auteurs
Langues
- Anglais
Année de publication
2022
Type
Orientations
Catégories
- Vaccins et dispositifs d'administration
Maladies
- COVID-19
Mots-clés
- Introduction de nouveaux vaccins
